Journal of the American Chemical Society
Article
polymer effects superior protection to heat, both added and as a
conjugate. Up to 81% retention of activity was observed under
these rigorous conditions. In this particular study, the
protective effect was not concentration dependent as adding
1 equiv and 100 equiv or conjugating the polymer gave similar
retention of activity for all molecular weights tested. However,
in other studies, which were longer in duration and at a
different concentration of protein, some concentration depend-
ence was observed (data not shown). Overall, the results
demonstrate that the glycopolymers stabilize lysozyme to high
temperatures. Furthermore the data suggest that the polymers
should be investigated further as an excipient and conjugate to
mollify the rigorous storage requirements that are typical for
proteins, particularly during transport where large fluctuations
in temperature may be observed.
Additional initial studies were conducted to compare
trehalose glycopolymers to the commonly used excipient
poly(ethylene glycol) (PEG). As such, PEG (Mn = 2−20
kDa) was combined with wild-type lysozyme at 1 or 100 equiv
and stressed by lyophilization or heat in an identical fashion as
before. The lyoprotective effect of PEG (see Supporting
Information, Figures S13 and S14) was found to depend on
weight. Glycopolymer at 1 equiv performed similarly to 1 equiv
of PEG, and 100 equiv of glycopolymer was a more effective
lyoprotectant than PEG depending on the molecular weight.
Thermal stability of PEG relative to the glycopolymers was also
investigated by exposing the relevant samples to a heat burden
of 90 °C for 1 h as before. Although PEG mitigates the thermal
stress to a minimal extent, the trehalose glycopolymer
outperforms PEG based on DP or molecular weight for all
samples tested (see Supporting Information, Figures S13 and
S14). The data collectively indicate that trehalose side chain
polymers are highly effective and superior to PEG as stabilizers
of a representative protein, lysozyme, to heat stress, and similar
or better stabilizers to lyophilization stress.
AUTHOR INFORMATION
■
Corresponding Author
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by the National Science Foundation
(CHE-1112550). The ARX 500 NMR data was obtained on
equipment supported by the National Science Foundation
(CHE-1048804). R.J.M. thanks the NSF and California
NanoSystems Institute for a Materials Creation Training
Program Fellowship. J.L. is grateful for additional funding
from a Yonsei International Foundation Scholarship. The
authors thank Thi (Kathy) Nguyen for preparing the thiolated
lysozyme.
REFERENCES
■
(1) Roberts, M. J.; Bentley, M. D.; Harris, J. M. Adv. Drug Delivery
Rev. 2002, 54, 459−476.
(2) Harris, J. M.; Chess, R. B. Nat. Rev. Drug Discovery 2003, 2, 214−
221.
(3) Alconcel, S. N. S.; Baas, A. S.; Maynard, H. D. Polym. Chem.
2011, 2, 1442−1448.
(4) Bischof, J. C.; He, X. M. Ann. N.Y. Acad. Sci. 2005, 1066, 12−33.
(5) Bays, E.; Tao, L.; Chang, C. W.; Maynard, H. D.
Biomacromolecules 2009, 10, 1777−1781.
(6) Mateo, C.; Lombardero, J.; Moreno, E.; Morales, A.; Bombino,
G.; Coloma, J.; Wims, L.; Morrison, S. L.; Perez, R. Hybridoma 2000,
19, 463−471.
(7) Lyczak, J. B.; Morrison, S. L. Arch. Virol. 1994, 139, 189−196.
(8) Syed, S.; Schuyler, P. D.; Kulczycky, M.; Sheffield, W. P. Blood
1997, 89, 3243−3252.
(9) Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L. H.; Langer, R.
Pharm. Res. 1991, 8, 713−720.
(10) Abuchowski, A.; Mccoy, J. R.; Palczuk, N. C.; Vanes, T.; Davis,
F. F. J. Biol. Chem. 1977, 252, 3582−3586.
CONCLUSION
■
(11) Wang, W. Int. J. Pharm. 2000, 203, 1−60.
(12) Oobatake, M.; Ooi, T. Prog. Biophys. Mol. Biol. 1993, 59, 237−
284.
A monomer based on trehalose has been synthesized through
installation of a vinylbenzylidene moiety to produce 4,6-O-(4-
vinylbenzylidene)-α,α-trehalose. Thiol-reactive CTAs were
utilized to effect RAFT polymerization of the glycomonomer
resulting in well-defined polymers with pendent trehalose
functionalities and thiol-reactive end groups. Glycopolymers of
different molecular weights were conjugated to hen egg white
lysozyme modified to contain a free thiol. It was found that a
longer spacer length between the reactive end group and
polymer chain provided better conjugation yields. The resulting
purified protein−glycopolymer conjugates exhibited active cell
lysis. When unconjugated polymers were added to wild-type
lysozyme, significant increases in resistance to lyophilization
and heat stresses were observed relative to wild-type protein,
protein stabilized by trehalose alone, or protein with added
PEG. When the polymer was conjugated to the protein, the
observed lyophilization stability was significantly enhanced. The
results suggest that the polymer could be potentially useful in
protein formulations.
(13) Maity, H.; O’Dell, C.; Srivastava, A.; Goldstein, J. Curr. Pharm.
Biotechnol. 2009, 10, 761−766.
(14) Chi, E. Y.; Krishnan, S.; Randolph, T. W.; Carpenter, J. F.
Pharm. Res. 2003, 20, 1325−1336.
(15) Pikal-Cleland, K. A.; Carpenter, J. F. J. Pharm. Sci. 2001, 90,
1255−1268.
(16) Crowe, J. H.; Carpenter, J. F.; Crowe, L. M.; Anchordoguy, T. J.
Cryobiology 1990, 27, 219−231.
(17) Carpenter, J. F.; Pikal, M. J.; Chang, B. S.; Randolph, T. W.
Pharm. Res. 1997, 14, 969−975.
(18) Prestrelski, S. J.; Tedeschi, N.; Arakawa, T.; Carpenter, J. F.
Biophys. J. 1993, 65, 661−671.
(19) Teramoto, N.; Sachinvala, N. D.; Shibata, M. Molecules 2008, 13,
1773−1816.
(20) Ohtake, S.; Kita, Y.; Arakawa, T. Adv. Drug Delivery Rev. 2011,
63, 1053−1073.
(21) Brewster, M. E.; Hora, M. S.; Simpkins, J. W.; Bodor, N. Pharm.
Res. 1991, 8, 792−795.
(22) Randolph, T. W. J. Pharm. Sci. 1997, 86, 1198−1203.
(23) Jorgensen, L.; Hostrup, S.; Moeller, E. H.; Grohganz, H. Expert
Opin. Drug Delivery 2009, 6, 1219−1230.
ASSOCIATED CONTENT
* Supporting Information
■
S
(24) Kaushik, J. K.; Bhat, R. J. Biol. Chem. 2003, 278, 26458−26465.
(25) Roughton, B. C.; Topp, E. M.; Camarda, K. V. Comput. Chem.
Eng. 2012, 36, 208−216.
Experimental details, NMRs, GPCs, UV−vis, kinetic data,
FPLC, and SDS-PAGE results for glycopolymer−protein
conjugates, and additional activity studies. This material is
(26) Arakawa, T.; Prestrelski, S. J.; Kenney, W. C.; Carpenter, J. F.
Adv. Drug Delivery Rev. 2001, 46, 307−326.
8478
dx.doi.org/10.1021/ja2120234 | J. Am. Chem. Soc. 2012, 134, 8474−8479